Glioma antigen

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

Because several antigenic peptides of human tumors that are recognized by T-lymphocytes have been identified, immune responses against cancer can now be artificially manipulated. Furthermore, since T-lymphocytes have been found to play an important role in the rejection of tumors by the host and also to have antigen-specific proliferative potentials and memory mechanisms, T-lymphocytes are thought to play a central role in cancer vaccination. Although multidisciplinary therapies have been attempted for the treatment of gliomas, the results remain unsatisfactory. For the development of new therapies against gliomas, it is required to identify tumor antigens as targets for specific immunotherapy. In this chapter, recent progress in research on glioma antigens is described.

Original languageEnglish
Title of host publicationGlioma
Subtitle of host publicationImmunotherapeutic Approaches
EditorsRyuya Yamanaka
Pages77-84
Number of pages8
DOIs
Publication statusPublished - 2012 Jul 3

Publication series

NameAdvances in Experimental Medicine and Biology
Volume746
ISSN (Print)0065-2598

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Glioma antigen'. Together they form a unique fingerprint.

  • Cite this

    Toda, M. (2012). Glioma antigen. In R. Yamanaka (Ed.), Glioma: Immunotherapeutic Approaches (pp. 77-84). (Advances in Experimental Medicine and Biology; Vol. 746). https://doi.org/10.1007/978-1-4614-3146-6_6